LaSalle Street Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.79M Sell
18,028
-1,665
-8% -$158K 2.08% 15
2019
Q2
$1.82M Hold
19,693
2.13% 15
2019
Q1
$1.86M Sell
19,693
-220
-1% -$19.2K 2.19% 14
2018
Q4
$1.28M Hold
19,913
1.83% 15
2018
Q3
$1.78M Buy
19,913
+6,603
+50% +$584K 2.08% 9
2018
Q2
$1.06M Hold
13,310
1.05% 39
2018
Q1
$1.19M Buy
13,310
+4,038
+44% +$388K 0.94% 37
2017
Q4
$968K Buy
9,272
+1,468
+19% +$166K 0.67% 49
2017
Q3
$1.14M Hold
7,804
0.84% 41
2017
Q2
$1.01M Hold
7,804
0.83% 40
2017
Q1
$971K Sell
7,804
-62
-0.8% -$7.42K 0.81% 42
2016
Q4
$910K Hold
7,866
0.81% 42
2016
Q3
$822K Hold
7,866
0.76% 42
2016
Q2
$776K Hold
7,866
0.74% 43
2016
Q1
$787K Buy
7,866
+3,471
+79% +$357K 0.77% 42
2015
Q4
$526K Sell
4,395
-469
-10% -$54.3K 0.52% 56
2015
Q3
$526K Hold
4,864
0.56% 54
2015
Q2
$563K Buy
+4,864
New +$556K 0.55% 55

Other funds holding CELG

LaSalle Street Capital Management's CELG Position: Q3 2019 in Review

LaSalle Street Capital Management reduced its Celgene Corp (CELG) stake by 8.5% in Q3 2019, selling an estimated $158K and leaving 18,028 shares worth $1.79M. The position accounts for 2.08% of the portfolio, ranked #15.

LaSalle Street Capital Management first reported a position in CELG in Q2 2015 and has held it in 18 quarters since. The position peaked at $1.86M in Q1 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • LaSalle Street Capital Management held 18,028 shares of Celgene Corp worth $1.79M as of Q3 2019.
  • LaSalle Street Capital Management sold 1,665 Celgene Corp shares in Q3 2019, an estimated $158K.
  • Celgene Corp made up 2.08% of LaSalle Street Capital Management's portfolio in Q3 2019, its #15 holding.
  • LaSalle Street Capital Management first reported a position in Celgene Corp in Q2 2015 and has held it in 18 quarters since.
  • LaSalle Street Capital Management's Celgene Corp position peaked at $1.86M in Q1 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on LaSalle Street Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.